Scientific Library of Tomsk State University

   E-catalog        

Normal view MARC view

Premalignant changes in the bronchial epithelium are prognostic factors of distant metastasis in non-small cell lung cancer patients O. V. Pankova, L. A. Tashireva, E. O. Rodionov [et al.]

Contributor(s): Pankova, Olga V | Tashireva, Liubov A | Rodionov, Evgeniy O | Miller, Sergey V | Tuzikov, Sergey A | Pismenny, Dmitry S | Gerashchenko, Tatiana S | Zavyalova, Marina V | Vtorushin, Sergey V | Denisov, Evgeny V | Perelmuter, Vladimir MMaterial type: ArticleArticleContent type: Текст Media type: электронный Subject(s): немелкоклеточный рак легкого | поражение бронхов | отдаленные метастазы | безметастатическая выживаемость | плоскоклеточная метаплазияGenre/Form: статьи в журналах Online resources: Click here to access online In: Frontiers in oncology Vol. 11. P. 771802 (1-10)Abstract: Background: The study assessed the possibility of dividing patients into groups based on the assessment of morphological changes in the epithelium of small-caliber bronchi located near the primary tumor in order to predict high and low risks of distant metastasis of non-small cell lung cancer. Methods: In 171 patients with non-small cell lung cancer (T1-4N0-3M0) in small-caliber bronchi taken at a distance of 3–5 cm from the tumor, various variants of morphological changes in the bronchial epithelium (basal cell hyperplasia (BCH), squamous cell metaplasia (SM), and dysplasia (D)) were assessed. Long-term results of treatment, namely, distant metastasis, were assessed after 2 and 5 years. Results: During the follow-up period, distant metastases were found in 35.1% (60/171) of patients. Most often, they were observed in patients of the high-risk group: BCH+SM−D−(51.6%, 40/95) and BCH−SM+D+ (54.4%, 6/11). Less often, distant metastases were observed in low-risk group patients: BCH+SM+D− (6.7%, 3/45) and BCH−SM−D−(10.0%, 2/20). Tumor size, grade, and stage were significant predictors of metastasis only in the high-risk group. The 5-year metastasis-free survival was better in the low-risk group of distant metastases. Conclusions: Isolated BCH or dysplasia in small bronchi distant from foci of tumor isassociated with a high-risk distant metastasis and less 5-year metastasis-free survival.
Tags from this library: No tags from this library for this title. Log in to add tags.
No physical items for this record

Библиогр.: 11 назв.

Background: The study assessed the possibility of dividing patients into groups based on the assessment of morphological changes in the epithelium of small-caliber bronchi located near the primary tumor in order to predict high and low risks of distant metastasis of non-small cell lung cancer. Methods: In 171 patients with non-small cell lung cancer (T1-4N0-3M0) in small-caliber bronchi taken at a distance of 3–5 cm from the tumor, various variants of morphological changes in the bronchial epithelium (basal cell hyperplasia (BCH), squamous cell metaplasia (SM), and dysplasia (D)) were assessed. Long-term results of treatment, namely, distant metastasis, were assessed after 2 and 5 years. Results: During the follow-up period, distant metastases were found in 35.1% (60/171) of patients. Most often, they were observed in patients of the high-risk group: BCH+SM−D−(51.6%, 40/95) and BCH−SM+D+ (54.4%, 6/11). Less often, distant metastases were observed in low-risk group patients: BCH+SM+D− (6.7%, 3/45) and BCH−SM−D−(10.0%, 2/20). Tumor size, grade, and stage were significant predictors of metastasis only in the high-risk group. The 5-year metastasis-free survival was better in the low-risk group of distant metastases. Conclusions: Isolated BCH or dysplasia in small bronchi distant from foci of tumor isassociated with a high-risk distant metastasis and less 5-year metastasis-free survival.

There are no comments on this title.

to post a comment.
Share